Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-125540
Filing Date
2024-12-04
Accepted
2024-12-04 16:28:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2429853d5_defa14a.htm DEFA14A 91707
2 GRAPHIC tm2429853d5_defa14aimg001.jpg GRAPHIC 205803
3 GRAPHIC tm2429853d5_defa14aimg002.jpg GRAPHIC 151877
4 GRAPHIC tm2429853d5_defa14aimg003.jpg GRAPHIC 13731
  Complete submission text file 0001104659-24-125540.txt   604936
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 241526530
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)